o | Encouraging worldwide representation; |
o | Stimulating debate, research and discovery;
|
o | Enhancing communication and participation among basic scientists, translational researchers and clinicians;
|
o | Liaising with the pharmaceutical industry in the development and delivery of new medicines and treatments for CNS diseases;
|
o | Encouraging integration and participation of young researchers;
|
o | Involving multidisciplinary approaches;
|
o | Disseminating and translating results to clinical practice;
|
o | Representing and advocating to policy makers, public and private funding agencies, and their representatives;
|
o | Advancing public education and awareness;
|
o | Developing liaison with patients and beneficiaries of research advances.
|